Who invested in Platelet BioGenesis?
Platelet BioGenesis's investors include Qiming Venture Partners USA, Ziff Capital Partners, MassChallenge, Qiming Venture Partners and Vivo Capital, and 2 more on record.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$102Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $35M sold, first sale Oct 2021
Reported by FinSMEsSEC filing: $26M sold, first sale Jun 2019
From the SEC filings it signed: 3 on the team.
On the board, as filediJoseph ItalianoMark McDadePhilip Reilly
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Platelet BioGenesis's investors include Qiming Venture Partners USA, Ziff Capital Partners, MassChallenge, Qiming Venture Partners and Vivo Capital, and 2 more on record.
Platelet BioGenesis has raised $102M across 2 rounds since 2019.
Platelet BioGenesis's most recent round was a Series B of $76M in Nov 2021.
Its most recent round, $76M in Nov 2021, is also its largest on record.
Platelet BioGenesis's first round on record, in Sept 2019, was backed by Qiming Venture Partners USA, Ziff Capital Partners and eCoast Angels and 1 others.
Platelet BioGenesis's latest named round is a Series B, in Nov 2021.
Platelet BioGenesis is based in the United States.
Qiming Venture Partners USA led the Series A in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.